UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000027631 |
|---|---|
| Receipt number | R000031630 |
| Scientific Title | Randomized phase II study of TJ-3020 in patients with unresectable advanced or recurrent pancreatic cancer receiving nab-Paclitaxel plus Gemcitabine |
| Date of disclosure of the study information | 2017/07/01 |
| Last modified on | 2018/01/31 22:34:14 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/06/04 18:51:24 | ||
| 2 | Update | 2017/08/08 15:12:32 | Public title Public title Acronym Acronym |
|
| 3 | Update | 2017/08/08 15:13:17 | Narrative objectives1 Narrative objectives1 |
|
| 4 | Update | 2017/08/08 15:14:09 | Interventions/Control_2 Interventions/Control_2 |
|
| 5 | Update | 2018/01/31 22:34:14 | Recruitment status |
